Inventor · disambiguated record
David Burstein
Also filed as: BURSTEIN DAVID · BURSTEIN DAVID E
16 granted patents·11 pending applications·140 citations·filing 1995–2025
93Inventor score
Files withUNIV CALIFORNIA19SINAI SCHOOL MEDICINE4BARZEL ADI1BURSTEIN DAVID E1ICAHN SCHOOL MED MOUNT SINAI1
Top patents by PatentIndex Score
27 records- 0198US11453866B2CASZ compositions and methods of useUNIV CALIFORNIA·Filed 2020·Granted Sep 27, 2022·13 cites·30 claims
- 0298US11441137B2CasZ compositions and methods of useUNIV CALIFORNIA·Filed 2020·Granted Sep 13, 2022·9 cites·29 claims
- 0398US11371031B2CasZ compositions and methods of useUNIV CALIFORNIA·Filed 2020·Granted Jun 28, 2022·9 cites·27 claims
- 0498US11180743B2CasZ compositions and methods of useUNIV CALIFORNIA·Filed 2020·Granted Nov 23, 2021·13 cites·19 claims
- 0598US10570415B2RNA-guided nucleic acid modifying enzymes and methods of use thereofUNIV CALIFORNIA·Filed 2018·Granted Feb 25, 2020·47 cites·30 claims
- 0696US11795472B2RNA-guided nucleic acid modifying enzymes and methods of use thereofUNIV CALIFORNIA·Filed 2019·Granted Oct 24, 2023·13 cites·28 claims
- 0795US11873504B2RNA-guided nucleic acid modifying enzymes and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Jan 16, 2024·10 cites·31 claims
- 0892US12258575B2RNA-guided nucleic acid modifying enzymes and methods of use thereofUNIV CALIFORNIA·Filed 2022·Granted Mar 25, 2025·1 cites·26 claims
- 0990US12264314B1CasZ compositions and methods of useUNIV CALIFORNIA·Filed 2023·Granted Apr 1, 2025·0 cites·30 claims
- 1088US11970719B2Class 2 CRISPR/Cas compositions and methods of useUNIV CALIFORNIA·Filed 2018·Granted Apr 30, 2024·3 cites·18 claims
- 1184US2023323319A1Casz compositions and methods of useUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1284US2024167052A1Rna-guided nucleic acid modifying enzymes and methods of use thereofUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1380US2025179470A1Casz compositions and methods of useUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 1478US2024301376A1Class 2 crispr/cas compositions and methods of useUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 1576US2020087640A1Casz compositions and methods of useUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1664US2015038596A1Differential Diagnosis Of Cancer And Other Conditions Based On Expression Of p63ICAHN SCHOOL MED MOUNT SINAI·Filed 2014·Application pending·0 cites
- 1763US11371062B2RNA-guided nucleic acid modifying enzymes and methods of use thereofUNIV CALIFORNIA·Filed 2017·Granted Jun 28, 2022·0 cites·28 claims
- 1861US2014072969A1Differential Diagnosis Of Cancer And Other Conditions Based On Expression Of p63SINAI SCHOOL MEDICINE·Filed 2013·Application pending·0 cites
- 1958US6972181B2Differential diagnosis of cancer and other conditions based on expression of p63SINAI SCHOOL MEDICINE·Filed 2002·Granted Dec 6, 2005·1 cites·7 claims
- 2056US8566040B2Method for searching for homing endonucleases, their genes and their targetsBARZEL ADI·Filed 2009·Granted Oct 22, 2013·2 cites·23 claims
- 2154US2006035292A1Differential diagnosis of cancer and other conditions based on expression of p63SINAI SCHOOL MEDICINE·Filed 2005·Application pending·0 cites
- 2252US12227753B2CasY compositions and methods of useUNIV CALIFORNIA·Filed 2018·Granted Feb 18, 2025·0 cites·16 claims
- 2351US2021284981A1Rna-guided nucleic acid modifying enzymes and methods of use thereofUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 2448US2020339967A1Cas12c compositions and methods of useUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 2547US5698410AHighly sensitive immunocytochemical method for diagnosis of malignant effusionsSINAI SCHOOL MEDICINE·Filed 1995·Granted Dec 16, 1997·15 cites·10 claims
- 2641US2020129848A1Word GameBURSTEIN DAVID E·Filed 2016·Application pending·0 cites
- 2730US5897991AHighly sensitive immunocytochemical method for diagnosis of malignant effusionsMOUNT SINAI MEDICAL CENTER·Filed 1997·Granted Apr 27, 1999·4 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when David Burstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →